OC-0425 Clinical experience with stereotactic MR- guided adaptive radiation therapy for pancreatic tumors

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Purpose or Objective The duodenum is the primary dose-limiting organ when performing SBRT for locally advanced pancreatic cancer (LAPC). With technical and imaging advancements, the incidence of grade ≥3 small bowel toxicity (bleeding, perforation, strictures) has decreased to
Original languageEnglish
Pages (from-to)S224-S225
JournalRadiotherapy and Oncology
Volume123
DOIs
Publication statusPublished - 2017

Cite this